KBIO COMPANY Inc. (KOSDAQ:038530)
South Korea flag South Korea · Delayed Price · Currency is KRW
234.00
+9.00 (4.00%)
At close: Apr 1, 2025, 3:30 PM KST

KBIO COMPANY Statistics

Total Valuation

KBIO COMPANY has a market cap or net worth of KRW 27.03 billion. The enterprise value is 26.05 billion.

Market Cap 27.03B
Enterprise Value 26.05B

Important Dates

The last earnings date was Thursday, March 20, 2025.

Earnings Date Mar 20, 2025
Ex-Dividend Date n/a

Share Statistics

KBIO COMPANY has 115.50 million shares outstanding. The number of shares has increased by 12.62% in one year.

Current Share Class n/a
Shares Outstanding 115.50M
Shares Change (YoY) +12.62%
Shares Change (QoQ) -1.16%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 77.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.35
PB Ratio 0.47
P/TBV Ratio 0.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.84
EV / Sales 0.34
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -136.88

Financial Position

The company has a current ratio of 7.35, with a Debt / Equity ratio of 0.01.

Current Ratio 7.35
Quick Ratio 6.28
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -3.97
Interest Coverage -14.23

Financial Efficiency

Return on equity (ROE) is -8.49% and return on invested capital (ROIC) is -0.58%.

Return on Equity (ROE) -8.49%
Return on Assets (ROA) -0.53%
Return on Invested Capital (ROIC) -0.58%
Return on Capital Employed (ROCE) -1.03%
Revenue Per Employee 2.32B
Profits Per Employee -205.80M
Employee Count 33
Asset Turnover 0.59
Inventory Turnover 15.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.55% in the last 52 weeks. The beta is -0.32, so KBIO COMPANY's price volatility has been lower than the market average.

Beta (5Y) -0.32
52-Week Price Change -27.55%
50-Day Moving Average 244.94
200-Day Moving Average 259.75
Relative Strength Index (RSI) 47.59
Average Volume (20 Days) 1,327,122

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, KBIO COMPANY had revenue of KRW 76.51 billion and -6.79 billion in losses. Loss per share was -59.00.

Revenue 76.51B
Gross Profit 11.66B
Operating Income -1.11B
Pretax Income -9.86B
Net Income -6.79B
EBITDA -25.92M
EBIT -1.11B
Loss Per Share -59.00
Full Income Statement

Balance Sheet

The company has 52.48 billion in cash and 754.97 million in debt, giving a net cash position of 51.73 billion or 447.86 per share.

Cash & Cash Equivalents 52.48B
Total Debt 754.97M
Net Cash 51.73B
Net Cash Per Share 447.86
Equity (Book Value) 107.08B
Book Value Per Share 494.34
Working Capital 61.03B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -119.17 million and capital expenditures -71.16 million, giving a free cash flow of -190.34 million.

Operating Cash Flow -119.17M
Capital Expenditures -71.16M
Free Cash Flow -190.34M
FCF Per Share -1.65
Full Cash Flow Statement

Margins

Gross margin is 15.24%, with operating and profit margins of -1.45% and -8.88%.

Gross Margin 15.24%
Operating Margin -1.45%
Pretax Margin -12.89%
Profit Margin -8.88%
EBITDA Margin -0.03%
EBIT Margin -1.45%
FCF Margin n/a

Dividends & Yields

KBIO COMPANY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.62%
Shareholder Yield -12.62%
Earnings Yield -25.13%
FCF Yield -0.70%

Stock Splits

The last stock split was on April 27, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date Apr 27, 2017
Split Type Reverse
Split Ratio 0.1

Scores

KBIO COMPANY has an Altman Z-Score of 2.49. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.49
Piotroski F-Score n/a